
Article 1 
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Article 2 
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 15 June 2016.
For the Commission
The President
Jean-Claude JUNCKER
ANNEX

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

((1)) in the sixth column, expiration of approval, of row 29, Ethofumesate, the date is replaced by ‘31 July 2017’;
((2)) in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by ‘31 October 2017’;
((3)) in the sixth column, expiration of approval, of row 41, Imazamox, the date is replaced by ‘31 July 2017’;
((4)) in the sixth column, expiration of approval, of row 42, Oxasulfuron, the date is replaced by ‘31 July 2017’;
((5)) in the sixth column, expiration of approval, of row 44, Foramsulfuron, the date is replaced by ‘31 July 2017’;
((6)) in the sixth column, expiration of approval, of row 46, Cyazofamid, the date is replaced by ‘31 July 2017’;
((7)) in the sixth column, expiration of approval, of row 47, 2,4-DB, the date is replaced by ‘31 October 2017’;
((8)) in the sixth column, expiration of approval, of row 48, Beta-cyfluthrin, the date is replaced by ‘31 October 2017’;
((9)) in the sixth column, expiration of approval, of row 50, Iprodione, the date is replaced by ‘31 October 2017’;
((10)) in the sixth column, expiration of approval, of row 51, Linuron, the date is replaced by ‘31 July 2017’;
((11)) in the sixth column, expiration of approval, of row 52, Maleic hydrazide, the date is replaced by ‘31 October 2017’;
((12)) in the sixth column, expiration of approval, of row 53, Pendimethalin, the date is replaced by ‘31 July 2017’;
((13)) in the sixth column, expiration of approval, of row 59, Trifloxystrobin, the date is replaced by ‘31 July 2017’;
((14)) in the sixth column, expiration of approval, of row 60, Carfentrazone ethyl, the date is replaced by ‘31 July 2017’;
((15)) in the sixth column, expiration of approval, of row 61, Mesotrione, the date is replaced by ‘31 July 2017’;
((16)) in the sixth column, expiration of approval, of row 62, Fenamidone, the date is replaced by ‘31 July 2017’;
((17)) in the sixth column, expiration of approval, of row 63, Isoxaflutole, the date is replaced by ‘31 July 2017’;
((18)) in the sixth column, expiration of approval, of row 64, Flurtamone, the date is replaced by ‘31 October 2017’;
((19)) in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘31 October 2017’;
((20)) in the sixth column, expiration of approval, of row 66, Iodosulfuron, the date is replaced by ‘31 October 2017’;
((21)) in the sixth column, expiration of approval, of row 67, Dimethenamid-P, the date is replaced by ‘31 October 2017’;
((22)) in the sixth column, expiration of approval, of row 68, Picoxystrobin, the date is replaced by ‘31 October 2017’;
((23)) in the sixth column, expiration of approval, of row 69, Fosthiazate, the date is replaced by ‘31 October 2017’;
((24)) in the sixth column, expiration of approval, of row 70, Silthiofam, the date is replaced by ‘31 October 2017’;
((25)) in the sixth column, expiration of approval, of row 71, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), the date is replaced by ‘31 October 2017’.
